CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
about
Relative contribution of genetic, individual, and self-efficacy factors to smoking cessation in a Chinese rural population.Perceptions of pharmacogenetic research to guide tobacco cessation by patients, providers and leaders in a tribal healthcare setting.Altered White Matter Integrity in Smokers Is Associated with Smoking Cessation Outcomes.The association between the nicotinic acetylcholine receptor α4 subunit gene (CHRNA4) rs1044396 and Internet gaming disorder in Korean male adults.Cognitive Control, the Anterior Cingulate, and Nicotinic Receptors: A Case of Heterozygote Advantage.Cholinergic receptor nicotinic alpha 5 subunit polymorphisms are associated with smoking cessation success in women.
P2860
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@ast
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@en
type
label
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@ast
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@en
prefLabel
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@ast
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@en
P2093
P2860
P356
P1476
CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
@en
P2093
Alexandre C Pereira
Jaqueline S Issa
Juliana Rocha Santos
Paulo C J L Santos
Paulo R X Tomaz
Tânia O Abe
P2860
P356
10.3389/FGENE.2015.00046
P577
2015-02-27T00:00:00Z